April 3, 2026Journal of Digestive Diseases0 citations
Association Between Asymmetric Dimethylarginine, Its Change, and Subclinical Carotid Atherosclerosis in Metabolic Dysfunction–Associated Steatotic Liver Disease
The study explores the relationship between asymmetric dimethylarginine (ADMA) levels and subclinical carotid atherosclerosis (SCA) in adults with metabolic dysfunction-associated steatotic liver disease (MASLD).
Measured levels of asymmetric dimethylarginine among adults with MASLD.
Assessed the prevalence of subclinical carotid atherosclerosis.
Examined changes in ADMA over a short-term period.
Higher ADMA levels correlate with increased prevalence of subclinical carotid atherosclerosis.
Short-term changes in ADMA levels may serve as early warning signs of SCA progression.
Abstract
ADMA is associated with the prevalence of SCA, and short-term dynamic changes in ADMA may represent early indicators for SCA progression in adults with MASLD.